LYPOSIN 20%: FAT EMULSION INJECTION.
The FAT EMULSION INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, special_features: WITH ADMINISTRATION SET, primary_container_type: BOTTLE, INFUSION, pharmaceutical_vehicle_type: AQUEOUS, primary_container_content_quantity: 500.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-127-4049, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| special_features | WITH ADMINISTRATION SET |
| primary_container_type | BOTTLE, INFUSION |
| pharmaceutical_vehicle_type | AQUEOUS |
| primary_container_content_quantity | 500.000 MILLILITERS |
| active_medicament_medicinal_strength | 2.500 PERCENTAGE, W/V GLYCERIN ACTIVE INGREDIENT AND 20.000 PERCENTAGE, W/V SAFFLOWER OIL ACTIVE INGREDIENT AND 1.20 PERCENTAGE, W/V EGG PHOSPHATIDES ACTIVE INGREDIENT |
| NSN | 6505-01-127-4049 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | BOTTLE, INFUSION |
| SPECIAL FEATURES | WITH ADMINISTRATION SET |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.500 PERCENTAGE, W/V GLYCERIN ACTIVE INGREDIENT AND 20.000 PERCENTAGE, W/V SAFFLOWER OIL ACTIVE INGREDIENT AND 1.20 PERCENTAGE, W/V EGG PHOSPHATIDES ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.